Skip to main content

Spatiotemporal trends and ecological risk assessment of volatile methylsiloxanes in Tokyo Bay catchment basin, Japan: River water and sewage treatment plant samples.

The Science of the total environment2025-04-05PubMed
Total: 76.0Innovation: 8Impact: 8Rigor: 7Citation: 8

Summary

Across 2013–2021, volatile methylsiloxanes (D3–D6, L3–L6) were widespread in Tokyo Bay catchment waters, peaking downstream of sewage treatment discharges. Significant annual declines in D4–D6 (−7.7% to −6.4%) and a decreasing ecological risk profile suggest regulatory measures are effective, despite levels near predicted no-effect thresholds.

Key Findings

  • VMSs (D3–D6, L3–L6) were widely detected in rivers (2.3–1190 ng/L), with highest levels downstream of STP discharges.
  • No consistent elevation was found downstream of silicone-manufacturing facilities except for D3.
  • Significant annual declines in D4–D6 (−7.7% to −6.4%) were observed between 2013 and 2021.
  • Ecological risk for D4–D6 decreased over time; 95th percentile field concentrations did not overlap with 5th percentile chronic NOECs, though levels were near predicted NOECs.

Clinical Implications

While not a clinical trial, these findings support counseling patients on environmentally safer product choices and inform clinicians’ advocacy for regulations limiting high-risk VMSs to reduce population exposure.

Why It Matters

Provides rare long-term surface water data linking regulatory actions to decreasing VMS levels and ecological risk, informing environmental policy for silicone-containing cosmetic ingredients.

Limitations

  • Human exposure and health outcomes were not assessed directly
  • Sampling intensity and exact sample counts were not specified in the abstract; potential spatial/temporal sampling variability

Future Directions

Integrate human biomonitoring and source apportionment to link environmental trends to exposure and health, and assess mixture toxicity and alternatives to high-risk cVMSs.

Study Information

Study Type
Cohort
Research Domain
Prevention
Evidence Level
III - Observational longitudinal monitoring without randomization
Study Design
OTHER